Skip to main content

Matthew Kelly

Adjunct Associate Professor of Pediatrics
Pediatrics, Infectious Diseases
3 Genome Court, MSRB3, Room 4128, DUMC 102346, Durham, NC 27710
5212 I St., Little Rock, AR 72205

Overview


My research is broadly focused on elucidating the complex interactions that exist between the host microbiome and exogenous pathogens that cause infections in children. We have several ongoing projects evaluating: 1) the impact of the upper respiratory microbiome on the risk of colonization and invasion by bacterial respiratory pathogens among infants in Botswana; 2) associations between the gut microbiome of pediatric stem cell transplant recipients and the risk of infections (bloodstream infection, C. difficile infection) and graft-versus-host disease; and 3) the role of the gut and respiratory microbiomes in mediating COVID-19 infection susceptibility and disease severity in children. Ultimately, I aim to develop strategies that use targeted modification of the microbiome for the prevention of infections in children.

Current Appointments & Affiliations


Adjunct Associate Professor of Pediatrics · 2025 - Present Pediatrics, Infectious Diseases, Pediatrics
Associate Research Professor in Molecular Genetics and Microbiology · 2023 - Present Molecular Genetics and Microbiology, Basic Science Departments
Member of the Human Vaccine Institute · 2024 - Present Duke Human Vaccine Institute, Institutes and Centers

In the News


Published February 23, 2024
Nasal Probiotic May Reduce Child Respiratory Infections
Published February 16, 2023
A Promising New Approach Against a Forgotten Killer
Published July 16, 2021
Children With Mild or Asymptomatic COVID Have Strong Antibodies Months Later

View All News

Recent Publications


Age-associated differences in mucosal and systemic host responses to SARS-CoV-2 infection.

Journal Article Nat Commun · March 10, 2025 Age is among the strongest risk factors for severe outcomes from SARS-CoV-2 infection. Here we describe upper respiratory tract (URT) and peripheral blood transcriptomes of 202 participants (age range of 1 week to 83 years), including 137 non-hospitalized ... Full text Open Access Link to item Cite

Metabolic capabilities are highly conserved among human nasal-associated Corynebacterium species in pangenomic analyses.

Journal Article mSystems · December 17, 2024 UNLABELLED: Corynebacterium species are globally ubiquitous in human nasal microbiota across the lifespan. Moreover, nasal microbiota profiles typified by higher relative abundances of Corynebacterium are often positively associated with health. Among the ... Full text Link to item Cite

Infectivity and Immunogenicity of Live-Attenuated Respiratory Syncytial Virus Vaccines in Human Immunodeficiency Virus-Exposed Uninfected Children.

Journal Article Open Forum Infect Dis · December 2024 BACKGROUND: Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory illness among young children. Human immunodeficiency virus (HIV)-exposed, uninfected (HEU) children experience a higher burden of RSV disease and have immune abno ... Full text Link to item Cite
View All Publications

Recent Grants


Stimulating Access to Research in Residency (StARR) - NIAID

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2018 - 2029

The impact of the oral microbiome on pulmonary function among people with HIV in Botswana

ResearchCo-Mentor · Awarded by National Heart, Lung, and Blood Institute · 2024 - 2029

An infection prevention dilemma: should we place patients with C. difficile colonization on contact precautions?

ResearchInvestigator · Awarded by Agency for Healthcare Research and Quality · 2024 - 2028

View All Grants

Education, Training & Certifications


Harvard Medical School · 2007 M.D.
Harvard University · 2007 M.P.H.